Aimwell Partners Inc. (AIMN)
| Market Cap | 2.00 -100.0% |
| Revenue (ttm) | n/a |
| Net Income | -505.11K |
| EPS | n/a |
| Shares Out | 3.16K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,317,500 |
| Open | 0.0007 |
| Previous Close | 0.0007 |
| Day's Range | 0.0006 - 0.0007 |
| 52-Week Range | 0.0005 - 5.9880 |
| Beta | 12.71 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Aimwell Partners
Aimwell Partners Inc. focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was formerly known as RONN Inc. and changes its name to Aimwell Partners Inc. in March 2026. Aimwell Partners Inc. was founded in 2013 and is based in Scottsdale, Arizona. [Read more]
News
The People Verifying Your Healthcare Should Not Be the People Selling It. AimwellBio Launches Provider Verification Registry in Connecticut.
The Registry's inaugural profile features Vital Care of Shelton, a woman-owned specialty infusion pharmacy, expanding AimwellBio's intelligence platform into provider transparency for patients and ref...
Patients Are Asking AI About Their Health; AimwellBio Wants Verified Physicians to Be Part of the Answer
Aimwell Partners Inc. launches a physician visibility program offering verified professional profiles, nationwide press opportunities, and complimentary AI and search visibility assessments for physic...
The GLP-1 Era Has a Trust Problem - AimwellBio is Building the Physician Network to Solve It
Company plans to integrate telemedicine into its verified health intelligence platform and opens a ten-seat Founding Physician Cohort spanning GLP-1 and metabolic care, hormone and menopause health, a...
AimwellBio Puts Its Global Intelligence Map in Public View, No Login Required, as Dr. Chris A. Jones Builds Out the Advisory Bench Behind it
Aimwell Partners Inc. (OTCID:AIMN) invites anyone to check the work at aimwellbio.com/atlas , confirms multiple physicians and prospective collaboration partners in active discussions following the Tr...
The IP Was Only Half the Acquisition: Aimwell Bio Closes the Trustr IP Purchase and Begins Bringing Aboard the People Who Built It
Definitive agreement executed with inventor Dr. Christopher A. Jones; contributors and strategic advisors from the platform's development history to be announced individually as their agreements are s...
AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors
Executed IP assignment brings a decade of technology, published research, and pharma-tested behavioral engagement capabilities into AimwellBio as the Company expands its scientific and medical advisor...
AimwellBio Secures Proprietary Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors
Executed IP assignment brings a decade of technology, published research, and pharma-tested behavioral engagement capabilities into AimwellBio as the Company expands its scientific and medical advisor...
AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency
Behavioral engagement technology carries documented institutional lineage spanning Oxford, the University of Vermont, Cornell, AMCP, and a Sanofi pilot program, as inventor Dr. Chris A. Jones joins Ai...
Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million
MIAMI, FL / ACCESS Newswire / August 6, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced that it has reached an agreement in principle to acquire a portfolio of...
The World's Most Valuable Healthcare Database May Already Exist, The Problem Is Nobody Knows Who to Trust Inside It
AimwellBio (AIMN) is building the Federated Health Intelligence Network - and preparing to introduce the physicians, scientists and healthcare experts whose knowledge deserves greater visibility. MIAM...
Aimwell Partners Inc. (OTC: AIMN) Opens No-Cost Observer Access and Publishes The Standard Behind Its Verified Intelligence Platform
Credentialed biopharma professionals can now access AimwellBio's Observer tier at no cost, while the company publishes the Adversarial Validation Standard, v1-the methodology behind every verified int...
The Doctors Who Actually Know Things Have Spent Twenty Years Being Cited and Never Credited. Aimwell Partners Inc. Is Building the Network That Puts Their Names on the Record
Aimwell Partners Inc. (OTCID:AIMN) publishes the contributor page of Christopher A. Jones, PhD, FRSM, as its Federated Health Intelligence Network expands through credentialed professional referral.
Aimwell Partners Inc. (OTC:AIMN) Confirms Advanced Discussions With Curated Life Sciences Capital Network
MIAMI, FL / ACCESS Newswire / July 15, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today confirmed it is engaged in advanced discussions with an exclusive, referral-based ...
Aimwell Partners Inc. (OTC: AIMN) Enters Final Negotiations to Acquire Healthcare Intellectual Property Independently Valued at $10 Million
MIAMI, FL / ACCESS Newswire / July 13, 2026 / Aimwell Partners Inc. (OTCID:AIMN) today announced that it has entered final-stage negotiations to acquire a portfolio of healthcare-related intellectual ...
The Professionals Arrived First - Now Their Institutions are Following: Aimwell Partners Inc. Confirms Enterprise Interest Driven by Its Credentialed Observer Network
MIAMI, FL / ACCESS Newswire / July 8, 2026 / Aimwell Partners Inc. (OTCID:AIMN) - Technology adoption rarely begins with procurement. It begins with the professionals doing the work.
Every AI Intelligence Platform Asks the Market to Trust Its Numbers. Aimwell Partners Inc. (OTC:AIMN) Just Opened the Data
419 regulatory, clinical, and research signals are now publicly available at aimwellbio.com/signals-no login, no sales call, and no requirement to take the company's word for anything. MIAMI, FL / ACC...
Aimwell Partners Inc. Publishes the Adversarial Validation Standard, v1, an Open Methodology Framework for Verifying AI-Generated Biopharma Intelligence
MIAMI, FL / ACCESS Newswire / July 1, 2026 / Aimwell Partners Inc. (OTCID:AIMN) ("Aimwell" or the "Company"), the parent company of AimwellBio, today announced the publication of the Adversarial Valid...
AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn Signup
Aimwell Partners Inc. (OTC PINK:AIMN) is actively onboarding doctors, scientists, researchers, and capital professionals into AimwellBio Observer, a credentialed intelligence network where members rea...
AIMN: As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor
With over one billion Americans' health records now breached and the largest incidents shifting to mission-critical third parties, Aimwell Partners Inc. is exploring verified infrastructure that adds ...
AimwellBio Expands Platform Capabilities to Strengthen the Infrastructure Behind Trusted Healthcare Intelligence
DENVER, CO / ACCESS Newswire / June 17, 2026 / Aimwell Partners Inc. (OTCID:AIMN) today announced an expansion of technical capabilities supporting AimwellBio, the Company's healthcare intelligence pl...
AimwellBio Opens Verified Observer Network to Healthcare, Research, and Capital Professionals at No Cost
Aimwell Partners Inc. (OTCID:AIMN) expands Observer access, a credentialed professional intelligence network for biopharma, inviting doctors, scientists, regulatory professionals, and capital allocato...
The Question No Telehealth Underwriter Wants Asked: When was Your Platform Last Breached, and Would You Even Know?
Aimwell Partners Inc. (OTC:AIMN) advances a verified collaboration mesh for healthcare intelligence, built on identity, encryption, and chain-of-custody integrity rather than the legacy internet infra...
As Healthcare's Software Leaders Race to Add AI, AimwellBio.com Moves to Build the Layer That Verifies It
Aimwell Partners Inc. explores verified biomedical intelligence infrastructure, positioning verification as the next essential layer in a proven, multi-billion-dollar medical software ecosystem DENVER...
AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In
A new professional intelligence network is forming around the people who shape clinical, research, regulatory, and capital decisions. Observer access is free.
Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself
DENVER, CO / ACCESS Newswire / May 27, 2026 / Aimwell Bio (OTC:AIMN) today issued commentary on what the company believes is an emerging shift within healthcare and biopharma infrastructure: the rise ...